Author:
Kanaoka Eri,Takahashi Kouji,Yoshikawa Takayoshi,Jizomoto Hiroaki,Nishihara Yoshitaka,Uchida Naomi,Maekawa Ryuji,Hirano Koichiro
Reference29 articles.
1. Evaluation new drugs: recombinant Interleukin-2;Bruton;Pharmacotherapy,1994
2. Active immunotherapy with transietly transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animals;Coveney;Surgery,1996
3. Adoptive immunotherapy of advanced solid tumor: an eight year clinical experience;Semino;Anticancer Res.,1999
4. Multidrug resistant malignant melanoma with intracranial metastasis responding to immunotherapy;Savas;Anticancer Res.,1999
5. Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancer;Schiphorst;Ann. Oncol.,1999
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioencapsulation of proteins in therapeutics;Smart Nanomaterials for Bioencapsulation;2022
2. Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities;International Journal of Biological Macromolecules;2021-05
3. Liposome-targeted delivery for highly potent drugs;Artificial Cells, Nanomedicine, and Biotechnology;2017-02-17
4. Emerging nanotechnologies for cancer immunotherapy;Experimental Biology and Medicine;2016-05
5. Tumor-specific gene delivery;Advances and Challenges in the Delivery of Nucleic Acid Therapeutics (Volume 2);2015-10